Arthritis Drug Tocilizumab Flops as COVID-19 Treatment
THURSDAY, Jan. 21, 2021 (HealthDay News) — The arthritis drug tocilizumab doesn’t help hospital patients with severe COVID-19, according to a new study that contradicts earlier research suggesting that it might aid recovery. In fact, patients receiving tocilizumab had a higher risk of death, so the trial was halted early.Continue Reading